SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response (Q106624228)

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ImageJ

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC7999926/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Immunology of COVID-19: Current State of the Science

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Origin and evolution of pathogenic coronaviruses

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

A Novel Coronavirus from Patients with Pneumonia in China, 2019

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Interferon-stimulated genes: a complex web of host defenses

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Human Coronavirus: Host-Pathogen Interaction

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Interplay between SARS-CoV-2 and the type I interferon response

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Attenuated interferon and pro-inflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Enhanced Viral Replication by Cellular Replicative Senescence

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

MDA7/IL-24 is an anti-viral factor that inhibits influenza virus replication

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Insights into ZIKV-Mediated Innate Immune Responses in Human Dermal Fibroblasts and Epidermal Keratinocytes

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

mRNA and miRNA profiling of Zika virus-infected human umbilical cord mesenchymal stem cells identifies miR-142-5p as an antiviral factor

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Whole Transcriptome Analyses Reveal Differential mRNA and microRNA Expression Profiles in Primary Human Dermal Fibroblasts Infected with Clinical or Vaccine Strains of Varicella Zoster Virus

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

SARS coronavirus and innate immunity

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication.

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

The coronavirus nucleocapsid is a multifunctional protein.

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection.

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism.

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Middle East respiratory syndrome coronavirus nucleocapsid protein suppresses type I and type III interferon induction by targeting RIG-I signaling

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Immune signaling by RIG-I-like receptors

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530

Ser386 phosphorylation of transcription factor IRF-3 induces dimerization and association with CBP/p300 without overall conformational change

26 April 2021

1 reference

https://api.crossref.org/works/10.3390/cells10030530